HUP0101215A2 - Kristályos formájú paroxetin - Google Patents
Kristályos formájú paroxetinInfo
- Publication number
- HUP0101215A2 HUP0101215A2 HU0101215A HUP0101215A HUP0101215A2 HU P0101215 A2 HUP0101215 A2 HU P0101215A2 HU 0101215 A HU0101215 A HU 0101215A HU P0101215 A HUP0101215 A HU P0101215A HU P0101215 A2 HUP0101215 A2 HU P0101215A2
- Authority
- HU
- Hungary
- Prior art keywords
- paroxetine
- product according
- depression
- treatment
- infrared spectrum
- Prior art date
Links
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 3
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 3
- 229960002296 paroxetine Drugs 0.000 title abstract 3
- 208000020401 Depressive disease Diseases 0.000 abstract 2
- 238000002329 infrared spectrum Methods 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 235000021588 free fatty acids Nutrition 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A tal lm ny krist lyos form ban lévő paroxetin szabad b zisravonatkozik. A krist lyos paroxetin szabad b zist egy az infrav"r"sspektrumban (nujol mull) k"rülbelül 3330 cm-1-nél lévő éles s vjellemzi, amely s v a folyékony forma infrav"r"s spektrum ban nincsjelen. A tal lm ny tov bbi t rgyait képezik a k"vetkezők: -gyógyszerkészítmény, amely egy tal lm ny szerinti terméket és gyógyszatilag elfogadható hordozót tartalmaz; - egy tal lm ny szerintitermék alkalmaz sa depresszió kezelésére szolg lógyógyszerkészítmények elő llít s ra; és - elj r s depressziókezelésére, amelynek sor n egy egy vagy t"bb rendellenességbenszenvedő betegnek egy tal lm ny szerinti termék hat sos vagyprofilaktikus mennyiségét adj k be. Ó
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9805581.7A GB9805581D0 (en) | 1998-03-16 | 1998-03-16 | Novel compounds |
| GBGB9813054.5A GB9813054D0 (en) | 1998-06-17 | 1998-06-17 | Novel compounds |
| GBGB9817115.0A GB9817115D0 (en) | 1998-08-06 | 1998-08-06 | Novel compounds |
| PCT/GB1999/000793 WO1999047519A1 (en) | 1998-03-16 | 1999-03-16 | Crystalline form of paroxetine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0101215A2 true HUP0101215A2 (hu) | 2002-04-29 |
| HUP0101215A3 HUP0101215A3 (en) | 2002-05-28 |
Family
ID=27269245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0101215A HUP0101215A3 (en) | 1998-03-16 | 1999-03-16 | Chrystalline form of paroxetine |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1064282A1 (hu) |
| JP (1) | JP2002506865A (hu) |
| KR (1) | KR20010041947A (hu) |
| CN (1) | CN1300286A (hu) |
| AP (1) | AP2000001907A0 (hu) |
| AU (1) | AU2847199A (hu) |
| BG (1) | BG104839A (hu) |
| BR (1) | BR9908825A (hu) |
| CA (1) | CA2323896A1 (hu) |
| EA (1) | EA200000946A1 (hu) |
| HU (1) | HUP0101215A3 (hu) |
| ID (1) | ID27596A (hu) |
| IL (1) | IL138390A0 (hu) |
| NO (1) | NO20004583L (hu) |
| PL (1) | PL342931A1 (hu) |
| SK (1) | SK13622000A3 (hu) |
| TR (1) | TR200002675T2 (hu) |
| WO (1) | WO1999047519A1 (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| GB9919052D0 (en) * | 1999-08-12 | 1999-10-13 | Smithkline Beecham Plc | Novel compound composition and process |
| US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| SK283608B6 (sk) * | 1995-02-06 | 2003-10-07 | Smithkline Beecham Plc | Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie |
-
1999
- 1999-03-16 PL PL99342931A patent/PL342931A1/xx unknown
- 1999-03-16 JP JP2000536714A patent/JP2002506865A/ja active Pending
- 1999-03-16 CN CN99806077A patent/CN1300286A/zh active Pending
- 1999-03-16 AP APAP/P/2000/001907A patent/AP2000001907A0/en unknown
- 1999-03-16 BR BR9908825-8A patent/BR9908825A/pt not_active Application Discontinuation
- 1999-03-16 HU HU0101215A patent/HUP0101215A3/hu unknown
- 1999-03-16 EA EA200000946A patent/EA200000946A1/ru unknown
- 1999-03-16 WO PCT/GB1999/000793 patent/WO1999047519A1/en not_active Application Discontinuation
- 1999-03-16 AU AU28471/99A patent/AU2847199A/en not_active Abandoned
- 1999-03-16 IL IL13839099A patent/IL138390A0/xx unknown
- 1999-03-16 EP EP99909104A patent/EP1064282A1/en not_active Withdrawn
- 1999-03-16 SK SK1362-2000A patent/SK13622000A3/sk unknown
- 1999-03-16 ID IDW20001813A patent/ID27596A/id unknown
- 1999-03-16 TR TR2000/02675T patent/TR200002675T2/xx unknown
- 1999-03-16 CA CA002323896A patent/CA2323896A1/en not_active Abandoned
- 1999-03-16 KR KR1020007010260A patent/KR20010041947A/ko not_active Application Discontinuation
-
2000
- 2000-09-14 NO NO20004583A patent/NO20004583L/no not_active Application Discontinuation
- 2000-10-11 BG BG104839A patent/BG104839A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ID27596A (id) | 2001-04-12 |
| EA200000946A1 (ru) | 2001-02-26 |
| HUP0101215A3 (en) | 2002-05-28 |
| BG104839A (en) | 2001-09-28 |
| KR20010041947A (ko) | 2001-05-25 |
| AU2847199A (en) | 1999-10-11 |
| CA2323896A1 (en) | 1999-09-23 |
| IL138390A0 (en) | 2001-10-31 |
| SK13622000A3 (sk) | 2001-03-12 |
| TR200002675T2 (tr) | 2000-12-21 |
| BR9908825A (pt) | 2000-11-21 |
| PL342931A1 (en) | 2001-07-16 |
| WO1999047519A1 (en) | 1999-09-23 |
| JP2002506865A (ja) | 2002-03-05 |
| CN1300286A (zh) | 2001-06-20 |
| NO20004583L (no) | 2000-09-15 |
| NO20004583D0 (no) | 2000-09-14 |
| EP1064282A1 (en) | 2001-01-03 |
| AP2000001907A0 (en) | 2000-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE205086T1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
| HUP0104702A2 (hu) | Klosztridium toxinszármazékok alkalmazása horkolási zajok elnyomására szolgáló gyógyászati készítmények előállítására | |
| HUP0400529A2 (hu) | Klórpromazin és pentamidin alkalmazása daganatképződéssel járó rendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására | |
| HUP0203198A2 (hu) | Tramadolvegyület és görcsoldó hatóanyagot tartalmazó gyógyászati készítmény, eljárás az előállítására és alkalmazása | |
| UA66825C2 (uk) | Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності | |
| HUP0100900A2 (hu) | Gyógyászatilag aktív morfolinolszármazékok, és az ezeket tartalmazó gyógyszerkészítmények | |
| PH31394A (en) | Certain Ä,2,5-thiadiazol-4-ylÜ-1-azabicyclo Ä3,2,1Üoctane derivaives and their pharmaceutical uses. | |
| HUP0002521A2 (hu) | A paclitaxel ónium sói, eljárás előállításukra, valamint ezeket tartalmazó gyógyszerkészítmények | |
| HUP9902105A2 (hu) | Angiosztatikus dipeptideket tartalmazó gyógyászati készítmények és ezek alkalmazása | |
| BG104727A (en) | Pharmaceutical composition of topiramate | |
| AU684059B2 (en) | Application of riluzole in the treatment of Parkinson's disease and Parkinsonian syndromes | |
| MX9706647A (es) | Composiciones farmaceuticas que comprenden inhibidores de oxidasa b de monoamina. | |
| KR960700716A (ko) | Aids-관련 신경 장애를 치료하기 위한 리루졸의 사용(use of riluzole for treating aids-related neural disorders) | |
| HUP0001014A2 (hu) | Gasztrointesztinális lipáz inhibitorok felhasználása | |
| ATE219670T1 (de) | Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia | |
| NZ320355A (en) | Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6- tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis | |
| BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
| ATE235901T1 (de) | Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen | |
| MX9603606A (es) | N-metil-n-[(1s)-1-fenil-2-((3s)-3-hidroxipirrolidin-1-il) etil]-2,2-difenil-acetamida. | |
| HK1079688A1 (en) | Statin product for enhancing cognitive maintenance | |
| HUP0101215A2 (hu) | Kristályos formájú paroxetin | |
| HUP0204391A2 (en) | The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders | |
| HUP0003803A2 (hu) | Flunarizin alkalmazása zöldhályog helyi kezelésére alkalmas gyógyszerkészítmény előállítására | |
| HUP0101326A2 (hu) | Paroxetinkompozíciók és eljárás az előállításukra | |
| GR3034062T3 (en) | Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease |